Eli Lilly Takes Legal Action Against Counterfeit Retatrutide Sales to Protect Pharmaceutical Integrity and Consumer Safety
Eli Lilly has initiated a legal battle against companies allegedly distributing unauthorized versions of their experimental weight-loss medication, retatrutide. In a series of lawsuits, five of which have been filed in Texas, the pharmaceutical giant claims these companies are engaging in illegal sales of unapproved drugs, potentially feeding a burgeoning global black market for counterfeit…